|
| Variables | Complications | OR (95% IC) | p-value | |
| Yes | No | ||||
| Age | ≥55 years | 26 (57.8) | 19 (52.2) | 1.02 (0.24 - 4.26) | 1 |
| <55 years | 13 (0.5) | 13 (0.5) | |||
| Sex | Men | 21 (0.5) | 21 (0.5) | 0.50 (0.13 - 2.03) | 0.33 |
| Women | 18 (62.1) | 11 (37.9) | |||
| Comorbidities/ Risk factors | Hypertension | 6 (60) | 4 (40) | 1.31 (0.19 - 9.02) | 1 |
| Diabetes | 4 (66.7) | 2 (33.3) | 1.77 (0.15 - 21.47) | 1 | |
| Tobacco | 5 (45.5) | 6 (54.5) | 0.51 (0.07 - 3.51) | 0.64 | |
| Alcohol | 13 (72.2) | 5 (27.8) | 4.08 (0.71 - 23.51) | 0.14 | |
| BMI | Malnourished | 2 (100) | 0 (0) | - | 1 |
| Normal | 8 (50) | 8 (50) | 0.80 (0.17 - 3.89) | 1 | |
| Overweight/Obese | 29 (54.7) | 24 (45.3) | 0.93 (0.20 - 4.29) | 1 | |
| WHO performance status | Stages 3 and 4 | 17 (53.1) | 15 (46.9) | 10.91 (1.19 - 100.41) | 0.02 |
| Stages 1 and 2 | 22 (56.4) | 17 (43.6) | |||
| ASA score | ASA >2 | 33 (50.8) | 32 (49.1) | - | 0.23 |
| ASA ≤ 2 | 4 (66.7) | 2 (33.3) | |||
| Diagnosis | Pancreatic head cancer | 27 (49.1) | 28 (50.9) | 0.31 (0.05 - 1.82) | 0.24 |
| Extrahepatic cholangiocarcinoma | 5 (62.5) | 3 (37.5) | 0.82 (0.10 - 6.62) | 1 | |
| Ampullary carcinoma | 7 (87.5) | 1 (12.5) | - | 0.11 | |
| cTNM stage | Stage I and II | 22 (62.9) | 13 (37.1) | 2.29 (0.59 - 8.94) | 0.23 |
| Stage III and IV | 17 (47.2) | 19 (52.8) | |||
| Surgical treatment | Curative | 7 (87.5) | 1 (12.5) | - | 0.11 |
| Palliative | 32 (50.8) | 31 (49.2) | |||